Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, is pleased to announce the appointment of Joe Torres-Ocasio as Senior Vice President and Chief Operating Officer (COO). Joe will lead Veranova’s global operations across its manufacturing network in Europe and North America, and will […]
Post Type Archives: News
Julius Clinical Welcomes Bassem Saleh as Chief Executive Officer
Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic diseases, is pleased to announce the appointment of Bassem Saleh as its new Chief Executive Officer. Mr. Saleh brings extensive leadership experience from both large and mid-sized clinical CROs, most recently serving as CEO of TFS HealthScience. Throughout […]
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
Amgen announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs. The planned investment will support increased drug production at the company’s biologics manufacturing facility in Juncos and integrate innovative advanced technologies throughout the operations process. It is expected to create nearly 750 jobs, including construction roles and new highly skilled […]
FDA Approves Eli Lilly Oral Breast Cancer Treatment
Eli Lilly announced U.S. FDA approval of imlunestrant, its treatment for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer whose disease progressed after at least one line of endocrine therapy, on September 25th. Marketed as Inluriyo, imlunestrant is an oral estrogen receptor antagonist treatment delivered via 200 mg tablets. According to a company […]
FUJIFILM Biotechnologies Celebrates the Grand Opening of its Commercial-Scale Cell Culture Manufacturing Site in North Carolina
FUJIFILM Biotechnologies today celebrated the grand opening of its manufacturing site in Holly Springs, North Carolina. The newest addition to FUJIFILM Biotechnologies’ global network represents one of the largest commercial-scale cell culture biomanufacturing sites in North America. The first phase of the planned $3.2 billion manufacturing site opens with a capacity of 8 x 20,000 […]
Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production
Takara Bio Europe announced the launch of Cellartis® MSC EV Wonder™, a defined, xeno-free medium engineered for the scalable production of extracellular vesicles (EVs) from human mesenchymal stem cells (MSCs). MSC-derived EVs are increasingly recognized as next-generation, cell-free therapeutic candidates, offering regenerative and immunomodulatory benefits without the safety concerns associated with administering intact MSCs. As […]
Hovione and Microinnova partner to advance modular flow chemistry for multi-purpose manufacturing
Hovione, an international integrated pharmaceutical development and manufacturing organization, and Microinnova Engineering, a recognized leader in continuous process intensification, today announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry. The companies will work together to test Microinnova’s modular manufacturing equipment in an industrial setting. The Microinnova equipment is designed […]
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics
RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived exosomes for both human and animal health applications, has announced a collaboration with Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), to provide cGMP manufacturing and technical support for commercial scale production of its Purified Exosome Product™ (PEP™) drug substance for […]
Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate Cardiomyocytes to Advance Cardiac Safety Research
Ncardia, a leader in stem cell–based solutions for drug discovery and safety assessment, today announced the launch of Ncyte® NHP-C vCardiomyocytes, the first commercially available ventricular-like cardiomyocytes derived from induced pluripotent stem cells (iPSCs) of cynomolgus monkeys. New Ncyte® NHP-C vCardiomyocytes provide a scalable, ethical and translational tool for cross-species cardiac studies. The innovation addresses […]
Merck and Siemens Extend Digital Services Partnership
On September 23rd, Merck and Siemens signed a Memorandum of Understanding extending their strategic partnership to accelerate digital transformation in the life sciences industry. The agreement centers on using digital-first solutions, including automation and AI, to close workflow gaps between drug discovery, development, and manufacturing. Before this agreement, the companies had also signed a prior […]